Have you heard about induced pluripotent stem cells (iPS cells), but don’t know exactly what they are and what they can do? If so, read on to learn the answers to frequently asked questions (FAQs) about iPS cells.
In this article:
A Beginner’s Guide to Stem Cell Therapy: Everything to Know
Stem cell therapy, also called regenerative medicine, is gaining traction around the globe. This procedure aims to improve the repair response of dysfunctional and damaged tissue via stem cell implantation. As such, it represents an innovative way of combating various diseases and injuries.
You may be aware there’s a lot of hearsay floating around the topic. Stem cell treatments are in the epicenter of heated debates. We’re going to ignore all that and explore two facts: the ability of stem cells to self-renew unlimitedly and repair tissues in our bodies. [Read more…]
Could MSC Therapeutics Revolutionize Modern Medicine as We Know It?
MCSs are multipotent progenitor cells capable of developing into a variety of cell types during human development, including adipocytes, chondrocytes, osteocytes, and cardiomyocytes. Population aging and an increasing prevalence of chronic disease are driving interest in MSC-based therapies. Over the past 150 years, the average human lifespan has doubled and continued increases in life-expectancy are expected. [Read more…]
Cord Blood Industry Consolidation Escalates in 2025
The global cord blood industry experienced strong growth from the early 1990’s through the late 2000’s, during which time more than 450 cord blood banking companies emerged worldwide. Approximately half of those companies owned their own labs, while the others were marketing entities or sub-contractors of storage space.
Starting about ten years ago, the market suddenly changed course. It entered a period of aggressive consolidation, cutting the global number of cord blood banks by approximately half.
Over the past decade, the cord blood industry has witnessed substantial consolidation, particularly within the United States, Europe, Asia, and Latin America. [Read more…]
Sanatela AT Medical Solutions Inc. Announces Groundbreaking Patent Issuance for Cancer Stem Cell Identification and Precision Treatment Platform
Rochester, NY, September 24, 2025 – After two decades of pioneering hematology and cancer stem cell research, Sanatela AT Medical Solutions Inc. proudly announces that the United States Patent and Trademark Office (USPTO) has officially issued its long-awaited patent for a revolutionary cancer detection and treatment platform. [Read more…]
- « Previous Page
- 1
- …
- 38
- 39
- 40
- 41
- 42
- …
- 334
- Next Page »